Products |

Aptus EndoStapling System

Related Content

Key findings demonstrate patients with aortic stenosis have substantial untreated mortality risk across all levels of aortic stenosis severity, but aortic valve replacement rates remain low even for patients with severe aortic stenosis
News | Endovascular Aortic Repair
Philippe Généreux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at TCT23

October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...

Home October 30, 2023
Home
Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.
News | Endovascular Aortic Repair
Imagen Technologies Announces FDA Clearance of Aorta-CAD

December 5, 2022 — Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the ...

Home December 05, 2022
Home
Clinical study evaluates treatment for endovascular aortic arch repair
News | Endovascular Aortic Repair
UH Harrington Heart and Vascular Institute Performs First TRIOMPHE Study Case in Northeast Ohio

October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

Home October 26, 2022
Home
Risk factors for IAE
News | Endovascular Aortic Repair
Assessing Complex Endovascular Aneurysm Repair

March 22, 2022 – A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of ...

Home March 22, 2022
Home
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
News | Endovascular Aortic Repair
Front Line Medical Technologies Expands Availability of its COBRA-OS

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...

Home February 18, 2022
Home
Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases.
News | Endovascular Aortic Repair
Low Profile Thoracic Aortic Endograft Device Reduces Complications and Expands Patient Pool

May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a ...

Home May 12, 2021
Home
Medtronic Recalls Unused Valiant Navion Thoracic Stent Grafts
News | Endovascular Aortic Repair
Medtronic Recalls Unused Valiant Navion Thoracic Stent Grafts

February 23, 2021 — Medtronic has voluntarily issued a global recall of unused Medtronic Valiant Navion thoracic stent ...

Home February 23, 2021
Home
Thoracic abdominal aortic stent graft used to treat Type B aortic dissections (TBAD). The STS and SVS released new reporting standards for TBAD.
News | Endovascular Aortic Repair
New Reporting Standards for Type B Aortic Dissections

January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting ...

Home January 31, 2020
Home
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years. Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Endovascular Aortic Repair
Rapid Aortic Aneurysm Growth Occurs in Presence of Blood Clot

January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with abdominal aortic aneurysms (AAA) ...

Home January 29, 2020
Home
The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch. #VIVA19 #VIVA2019
News | Endovascular Aortic Repair
Nexus Arch Branch Stent Graft System Shows Positive Mid-term Results

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

Home November 11, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now